Changing clinical patterns and increasing prevalence in CADASIL

F C Moreton1, S S M Razvi, R Davidson

  • 1Institute of Neuroscience and Psychology, University of Glasgow, Southern General Hospital, Glasgow, UK.

Insights

Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) affects at least 4.6 per 100,000 adults. This study reveals a potentially later age of first stroke and highlights the importance of considering CADASIL in older stroke patients.

Area of Science:

  • Neurology
  • Genetics
  • Vascular Biology

Background:

  • Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic small vessel disease leading to recurrent strokes.
  • Phenotypic variability exists, with early descriptions suggesting dementia and disability onset in the fifth decade.

Purpose of the Study:

  • To determine the prevalence and clinical characteristics of CADASIL in the west of Scotland.
  • To investigate the impact of diagnostic timing on clinical outcomes.

Main Methods:

  • Retrospective review of clinical records from a specialist CADASIL clinic.
  • Analysis of NOTCH3 mutations and pedigree data to estimate prevalence.
  • Stratification of patients by age and date of diagnosis to assess clinical outcomes.

Main Results:

  • Identified 49 pedigrees with 21 different NOTCH3 mutations, predominantly in exon 4.
  • Established a disease prevalence of 4.6 per 100,000 adults in Glasgow.
  • Observed a median age of first stroke in women of 57 years, and a later age of stroke onset in men diagnosed more recently (56 years vs. 46 years).
  • Found that 38% of patients over 58 were living independently and 61% were mobile without aids.

Conclusions:

  • CADASIL prevalence is at least 4.6 per 100,000 adults, with mutation prevalence at 10.7 per 100,000.
  • The median age of first stroke may be later than previously reported.
  • CADASIL should be considered in the differential diagnosis of stroke, even in older individuals.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
33
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
12
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19